Anemia (pt 2/3) Hemostasis & Anti-coagulation, Heparin, Warfarin Flashcards

1
Q

What are the 4 things an ideal anti-coagulant would do? (Blue Box!)

A

1) Prevent pathologic thrombosis
2) Limit reperfusion injury
3) Allow a normal response to vascular injury
4) Limit bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is hemostasis?

A

-How the body maintains fluidity of the blood
-Includes repair of vascular injury
-A balance of minimizing blood loss while preventing inadequate perfusion and thrombosis (vessel occlusion)
-Hemorrhage or thrombosis = a breakdown of hemostatic mechanisms
-Primary Hemostasis – formation of the platelet plug
-Secondary Hemostasis – formation of fibrin (coagulation cascade)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 3 steps of Primary Hemostasis?

A

1) Adhesion
2) Activation
3) Aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What occurs during the Adhesion phase of Primary Hemostasis?

A

When vascular endothelium is damaged and the subendothelium is exposed, vWF anchors platelets to the collagen layer of the subendothelium.
-Collagen binds to GP1a receptor
-vWF binds to GP1b receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What occurs during the Activation phase of Primary Hemostasis?

A

1) Prothrombin (Factor II) is converted to Thrombin (Factor IIa)
2) Thrombin combines with the Thrombin receptor on the plt surface to activate the platelet
3) Platelet undergoes a morphological change to increase its surface area, so there is more platelet available to interact with other platelets.
4) Platelet releases mediators necessary for aggregation (Thromboxane A2 and ADP). Serotonin is released as well (causes vasoconstriction to prevent unnecessary bleeding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What occurs during the Aggregation phase of Primary Hemostasis?

A

1) Thromboxane A2 and ADP uncover the fibrinogen receptors (GP IIb/IIIa), allowing fibrinogen to be able to bind to its receptor.
2) Fibrinogen (I) attaches to its receptor and links the platelets to each other, producing a water-soluble, unstable, and friable clot = “white clot”.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why does blood coagulate?

A

Due to the transformation of soluble Fibrinogen into insoluble Fibrin by the enzyme Thrombin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Secondary Hemostasis?

A

The Coagulation Cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What triggers the Extrinsic Pathway?

A

Damage outside the blood vessels.
1) Damage triggers the release of Thromboplastin (AKA Tissue Factor AKA Factor III) from damaged cells
2) Thromboplastin activates Factor VII → VIIa
3) Factor VIIa + Factor IV (Calcium) on the surface of the platelet activates Factor X → Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the primary physiologic initiator of coagulation? !!

A

Thromboplastin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What triggers the Intrinsic pathway?

A

Triggered by damage inside the blood itself, or when it gets exposed to collagen.
1) Trauma to the blood itself or exposure of the blood to collagen in a traumatized blood vessel wall activates Factor XII → XIIa
2) XIIa activates factor XI → XIa
3) XIa activates factor IX → IXa
4) IXa combines on the platelet surface with Factors VIII and IV and activates Factor X → Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the steps of the Common Pathway?

A

1) Factor Xa combines on the platelet surface with activated Factor V → Va and Factor IV = conversion of Prothrombin (II) to Thrombin (IIa). -Factor X + help of others activates Factor II to IIa.
2) Thrombin converts Fibrinogen (I) to Fibrin (Ia)
3) Fibrin (I) cross-linking occurs if/when Fibrin(I) is in the presence of Factor XIII.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What does Factor IV (Calcium) Do?

A

Factor IV (Calcium) helps position clotting factors on the surface of the platelet so biochemical reactions can occur. Calcium is located on the surface of the platelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Thrombin’s role in hemostasis?

A

1) Proteolytically cleaves small peptides from Fibrinogen (I) to form Fibrin (Ia) clot.
2) Activates upstream clotting factors leading to more Thrombin (sort of like positive feedback)
-Remember in Primary Hemostasis that Thrombin is responsible for plt activation
3) Activates Factor XIII to cross-link Fibrin(I), stabilizing the clot
4) Potent platelet activator and potentiates platelet growth
5) Anti-coagulant effect through activation of Protein C
-Attenuates the clotting process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Under normal circumstances, repair of vascular injury occurs without ________ and _____________ ___________.

A

Under normal circumstances, repair of vascular injury occurs without thrombosis and downstream ischemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Antithrombin III?

A

Forms complexes with and neutralizes:
-Final Common Pathway: Factors IIa & Xa
-Intrinsic Pathway: Factors IX, XIa, and XIIa

A required cofactor for Heparin.
Antithrombin deficiency is the most common reason a patient is unresponsive to Heparin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What do All anti-coagulants and fibrinolytic drugs have as their principle toxicity?

A

Increased risk of bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How do Indirect Thrombin Inhibitors cause their effects?

A

Effect is caused by their interaction with Antithrombin III (to prevent thrombin from actually working).
-Unfractionated Heparin (UFH) a.k.a. High-Molecular-Weight (HMW) Heparin
-Low-Molecular-Weight (LMW) Heparin (Has a higher ratio of anti-10a (against activated factor 10) than activated factor II activity than unfractionated heparin)
-Fondaparinux
-Couramins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

The combination of AT III with unfractionated heparin increases degradation of both ______ and _______.

A

The combination of AT III with unfractionated heparin increases degradation of both factor Xa and thrombin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The combination of ATIII with fondaparinux or LMW heparin more selectively increases degradation of ________.

A

The combination of ATIII with fondaparinux or LMW heparin more selectively increases degradation of Factor Xa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is Heparin’s MOA?

A

-Binds tightly to the Antithrombin III and causes a conformational change → exposes the active site for a more rapid interaction with the clotting factors
-Accelerates the actions of Antithrombin III 1000-fold
-Once the antithrombin-clotting factor complex is formed, heparin is released intact to bind with additional antithrombin (and inactivate more thrombin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Unfractionated (HMW) Heparin has a high affinity for AT III and inhibits:

A

Factors IIa, IXa, and Xa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

LMW Heparin (Enoxaparin, Dalteparin, etc) inhibits ______, but has less of an effect on _______.

A

LMW Heparin (Enoxaparin, Dalteparin, etc) inhibits Factor Xa, but has less of an effect on Thrombin (not as much of an effect on Factor IIa).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the pros of LMW Heparin compared to Unfractionated?

A

-Equal Efficacy
-Increased bioavailability from SQ site
-Less frequent dosing requirements
-More predictable response, less need for blood monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What do you need to check before initiating Heparin therapy?

A

-Assess pt history of bleeding prior to initiating treatment
-Draw baseline coagulation panel

Check Anti-Xa units in high-risk patients:
-Assesses the heparin concentration but not the integrity of the Intrinsic Pathway
-Available on most automated coagulation instruments

26
Q

Does Heparin break down existing clots?

A

No; Heparin prevents clots from forming or growing larger

27
Q

Why isn’t Heparin given IM?

A

Given SQ or IV, never IM due to risk of hematoma at site of IM injection.

28
Q

In what situations is LMW Heparin preferred?

A

Intermittent heparin administration b/c no monitoring is required in most patients.
-Weight based dosing = predictable pharmacokinetics and plasma levels in patients with normal renal function
-Use with caution in patients with renal insufficiency or body weight > 150kg
-LMW levels not routinely measured EXCEPT in pts with renal insufficiency, obesity and pregnancy
-Measure Anti-Xa units to guide therapy as needed

29
Q

What is Enoxaparin full dose?

A

1mg/kg SQ every 12 hours

30
Q

What is Heparin used in the prevention and treatment of?

A

Venous thromboembolic disease
Arterial thrombosis
Thrombus prevention in cardiac or arterial surgery

31
Q

What do you want your lab values to be for a aPTT in a patient receiving Heparin therapy?

A

1.5-2.5 baseline

32
Q

What lab test is used to measure both LMW and UFH?

A

Partial Thromboplastin Time (PTT)
-Measures the intrinsic pathway

33
Q

What lab tests are specific to UFH?

A

-Protamine titration
-Anti-Xa units

34
Q

What is the loading dose for UFH?

A

80-100 units/kg - use actual body weight

35
Q

What is the Maintenance Dose for UFH?

A

15-22 units/kg per hour

36
Q

What is the low dose for prophylaxis with UFH?

A

5000U SQ every 8-12 hrs

37
Q

What are the symptoms of Heparin Toxicity?

A

-Bleeding!!! Inc risk in elderly women & pts with renal failure
-Allergy
-Alopecia (reversible)
-Osteoporosis/Fractures
-Mineralocorticoid Deficiency
-HIT

38
Q

What is Heparin-Induced Thrombocytopenia (HIT)?

A

-Systemic hypercoagulable state
-Incidence = 1-4% of patients treated with UFH
-M&M associated with thrombotic events, venous > arterial
-Skin necrosis
-Monitor platelet counts
-New thrombi after Heparin initiation ↑ suspicion of HIT
-Treat by discontinuing Heparin and starting Argatroban (direct thrombin inhibitor)

39
Q

Which patients are at increased risk for HIT?

A

-Surgical patients are at greatest risk
-Higher risk in pts with UFH (bovine > porcine) versus LMW heparin

-Incidence is lower in pediatric pts outside of the critical care unit
-Rare in pregnant women

40
Q

Peripheral incidence of a thrombosis increases when?

A

In an extremity with an indwelling catheter

41
Q

Why do you monitor platelet counts when suspecting HIT?

A

Thrombocytopenia appearing in a time frame consistent with an immune response (first few days of therapy) to heparin should be considered suspicious for HIT

42
Q

What do you do for Heparin Reversal?

A

1) Stop the Heparin
2) Administer Protamine Sulfate

-Heparin 100 U = Protamine 1 mg IV (no more than 50mg in 10 min)
-Enoxaparin 1mg = Protamine 1 mg IV (Not Fondaparinux or Danaparoid)

43
Q

What does Protamine Sulfate do?

A

A positively charged molecule that combines with Heparin (negatively charged) to form a stable complex.
-NO Anticoagulant actions
-Only partial reversal of Enoxaparin (LMWH)

44
Q

What are C/Is to Heparin therapy?

A

HIT
Hypersensitivity
Active bleeding
Hemophilia
Significant thrombocytopenia
Purpura
Severe hypertension
Intracranial hemorrhage
Infective endocarditis
Active TB
Ulcerative lesions of the GI tract
Threatened spontaneous abortion
Visceral carcinoma
Advanced hepatic or renal disease
Pts who have recently had surgery of the brain, spinal cord or eye
Pregnancy unless clearly indicated as there is no apparent placental transfer

45
Q

What pathway does Coumadin work on?

A

Extrinsic Pathway

46
Q

What are the Pharmacokinetics about Coumadin?

A

-Racemic mixture (S-warfarin is 4x more potent than R-warfarin)
-Sodium salt with 100% bioavailability
-99% bound to plasma albumin
-Small volume of distribution
-Half-life = 36 hours (difficult to initially become therapeutic)

47
Q

What is the MOA of Warfarin? (Blue Box!)

A

Blocks the y-carboxylation of glutamate residues in:
-Factors II, VII, IX, & X
-Anticoagulant Protein C & S

Results in biologically inactive coagulation factors.

48
Q

How does Warfarin inhibit Vitamin K?

A

-Vit K moves through an oxidation-reduction cycle in order to first donate an electron to y-glutamyl carboxylase and then receive one so it can be recycled to make more factors
-y-glutamyl carboxylase is needed to convert factors II, VII, IX, & X to their functional forms
-Warfarin prevents the reduction reaction that allows Vit K to be recycled
-Warfarin is INDIRECT (not acting directly on 2,7,9,10). Actually works on Vit K that is needed for these factors.

49
Q

Why does Warfarin take awhile to onset?

A

Blocks creation of more factors, not breaking down existing factors. Takes awhile to onset. Have to wait for existing factors to die naturally.
-Inhibits synthesis, but does not alter degradation.

50
Q

List the Vitamin K Dependent Factors from shortest to longest half-lives.

A

1) VII = 6 hrs
2) Protein C = short, like Factor VII
3) IX = 24 hrs
4) X = 40 hrs
5) II = 60 hrs

Lose function of Factor VII and Protein C first.

51
Q

Why is there a potential hypercoagulable state with initial Warfarin therapy?

A

Potential for transient, hypercoagulable state as Protein C is inhibited and 2,9,10 are not yet inhibited due to their long half-lives

52
Q

What do you also start patients on immediately when starting Warfarin for the first time? (Blue Box!)

A

Start patients on Heparin to achieve immediate anti-coagulation in the acute PE or DVT.
-Overlapping therapy between Heparin and Warfarin is generally 5-7 days.

53
Q

How does Warfarin effect the Prothrombin Time (PT)?

A

-The PT takes approximately 1 wk to adjust to a therapeutic level and then maintenance doses of 5-7 mg can be started
-PT should be increased to a level indicating 25% of normal PT activity
-If PT activity < 20% therapy should be stopped or reduced until > 20%

54
Q

How do you calculate INR?

A

patient PT time/mean of normal PT times for the lab

55
Q

How does Warfarin effect the INR?

A

-Therapeutic INR for prophylaxis and treatment of thrombotic disease is 2-3
-High risk (ex. Artificial heart valves) = 2.5-3.5
-For a patient with Warfarin Resistance, the INR may need to be raised or anticoagulation therapy changed to a different agent

56
Q

What is Warfarin resistance?

A

-Resistance is defined as experiencing an event despite being within the designated therapeutic range
-Seen in pts with advanced cancers typically GI in origin
LMW is superior to Warfarin in preventing venous thrombosis in pts with cancer

57
Q

How do you reverse Warfarin?

A

1) Stop warfarin therapy and establish normal activity of clotting factors
3) Administer agents based on severity. Drug cessation may be enough in stable pts that are not bleeding
-Oral or parenteral Vitamin K1 (phytonadione)
-FFP
-Recombinant factor VII (rFVIIa)
-4F PCC (Prothrombin Complex Concentrate) = concentrate of II, VII, IX & X

Note the long half-life of Warfarin → reversal may need to be repeated

58
Q

When is Warfarin contraindicated?

A

Pregnancy:
-Crosses the placenta →hemorrhagic disorders in the fetus
-Can affect the y-carboxyglutamate in fetal bone and blood → abnormal bone
-Heparin is safer choice in pregnancy

Inherited Deficiency of Protein C:
-Develop cutaneous necrosis within the first few weeks of therapy
-Can cause infarction of breast, fatty tissue, intestines and extremities
-Venous thrombosis develops due to the hypercoagulable state from Warfarin induced ↓ Protein C

59
Q

What Drugs increase PT with Warfarin?

A

Pharmacokinetics:
-Amiodarone
-Fluconazole
-Cimetidine
-Disulfiram

Pharmacodynamics:
-ASA at high doses
-Cephalosporins
-Heparin, Argatroban, etc

60
Q

What Drugs decrease PT with Warfarin?

A

Pharmacokinetics:
-Barbituates
-Rifampin
-Cholestyramine

Pharmacodynamics:
-Diuretics
-Vit K